English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, September 24, 2024
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
康哲药业:磷酸芦可替尼乳膏(白癜风)中国上市许可申请已获受理
Friday, August 16, 2024
康哲藥業(00867)發佈2024年中期業績:營業額和利潤環比均穩步提升
Thursday, June 29, 2023
China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global
Friday, August 16, 2024
康哲药业(00867)发布2024年中期业绩:营业额和利润环比均稳步提升
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023
Tuesday, August 6, 2024
康哲药业:甲氨蝶呤注射液增加类风湿关节炎适应症中国NDA获批(更正版)
康哲藥業:甲氨蝶呤注射液增加類風濕關節炎適應症中國NDA獲批
Monday, August 5, 2024
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575